ClinConnect ClinConnect Logo
Search / Trial NCT03897374

Strategic Targeting for Optimal Prevention of Cancer

Launched by CLINLOGIC LLC · Mar 28, 2019

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Strategic Targeting for Optimal Prevention of Cancer," is focused on improving the early detection of cancer. The main goal is to collect information over time to see how well hereditary cancer genomic testing—essentially a genetic test that looks for inherited cancer risks—can help doctors understand a patient’s overall risk for cancer. This knowledge may guide doctors in taking preventive actions, which could lead to earlier detection and treatment of cancer.

To participate in this trial, individuals must be 65 years or older and have had a hereditary cancer test ordered by their doctor because it was medically necessary. Participants should either have a history of cancer themselves or have a family member who has had cancer. The trial is currently recruiting participants, and those who join can expect to share their medical history and undergo genetic testing. It’s important to note that individuals who are currently hospitalized, incarcerated, or unable to provide accurate health information due to mental incapacity are not eligible to participate. This study aims to enhance our understanding of cancer risks and improve prevention strategies for those most at risk.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Study subjects may be included in the Clinical Trial if they meet all of the following inclusion criteria:
  • individuals, ages 65 years or older;
  • must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
  • hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
  • study subject has or had cancer
  • study subject has at least one family member with cirrent or past cancer
  • Exclusion Criteria:
  • Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
  • study subject is unable to provide an accurate history due to mental incapacity
  • study subject is currently abusing illicit and/or prescription drugs;

About Clinlogic Llc

Clinlogic LLC is a leading clinical trial sponsor dedicated to advancing medical research through innovative study designs and robust project management. With a focus on improving patient outcomes, Clinlogic partners with healthcare providers, research institutions, and pharmaceutical companies to facilitate the development of cutting-edge therapies and treatments. The company leverages its expertise in regulatory compliance, data analytics, and patient recruitment to streamline the clinical trial process, ensuring high-quality results that contribute to the evolving landscape of healthcare. Committed to scientific integrity and ethical standards, Clinlogic LLC is at the forefront of transforming clinical research into actionable medical solutions.

Locations

Prosper, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials